Davis Investment Partners’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Davis Investment Partners’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.69M	Sell	10,855 -662	-6%	-$143K	0.82%	19
2026 Q1	$2.31M	Buy	11,517 +6,817	+145%	+$1.41M	0.82%	19
2025 Q4	$976K	Hold	4,700	–	–	0.34%	52
2025 Q3	$872K	Hold	4,700	–	–	0.3%	54
2025 Q2	$762K	Hold	4,700	–	–	0.27%	61
2025 Q1	$732K	Hold	4,700	–	–	0.32%	56
2024 Q4	$805K	Hold	4,700	–	–	0.34%	56
2024 Q3	$810K	Hold	4,700	–	–	0.34%	56
2024 Q2	$754K	Hold	4,700	–	–	0.31%	60
2024 Q1	$709K	Hold	4,700	–	–	0.31%	58
2023 Q4	$744K	Hold	4,700	–	–	0.36%	50
2023 Q3	$689K	Hold	4,700	–	–	0.37%	50
2023 Q2	$738K	Hold	4,700	–	–	0.35%	52
2023 Q1	$727K	Hold	4,700	–	–	0.39%	42
2022 Q4	$761K	Buy	+4,700	New	+$693K	0.38%	46

Other funds holding FBT

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Bessemer Group Woodbridge, New Jersey $72.7B AUM 39.36% 1-Year Est. Return

BFG

Berger Financial Group Plymouth, Minnesota $1.96B AUM 20.58% 1-Year Est. Return

Davis Investment Partners's FBT Position: Q2 2026 in Review

Davis Investment Partners reduced its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 5.7% in Q2 2026, selling an estimated $143K and leaving 10,855 shares worth $2.69M. The position accounts for 0.82% of the portfolio, ranked #19.

Davis Investment Partners first reported a position in FBT in Q4 2022 and has held it in 15 quarters since. 339 funds tracked by Wall St. Rank hold FBT as of Q2 2026.

Davis Investment Partners held 10,855 shares of First Trust NYSE Arca Biotechnology Index Fund worth $2.69M as of Q2 2026.
Davis Investment Partners sold 662 First Trust NYSE Arca Biotechnology Index Fund shares in Q2 2026, an estimated $143K.
First Trust NYSE Arca Biotechnology Index Fund made up 0.82% of Davis Investment Partners's portfolio in Q2 2026, its #19 holding.
Davis Investment Partners first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2022 and has held it in 15 quarters since.
339 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2026.

Based on Davis Investment Partners's 13F filing for Q2 2026, filed 7 Aug 2026.